Navigation Links
Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
Date:7/16/2008

NEWPORT NEWS, Va., July 16 /PRNewswire/ -- Dilon Technologies, makers of a gamma imaging system optimized for early breast cancer detection, today announced a three-year agreement with Amerinet, a leading national group purchasing organization. Effective immediately, the relationship offers Amerinet's 26,000 acute and non-acute healthcare providers and their patients' access to the Dilon 6800 Gamma Camera, used in detecting and diagnosing very early stage breast cancers.

"Dilon Technologies is committed to enhancing the standard of healthcare in communities across the nation, said David Rom, National Accounts Director for Dilon. "This strategic partnership with Amerinet will help physicians with difficult-to-diagnose patients and continue to aid in the fight against breast cancer."

The Dilon 6800 performs a molecular breast imaging technique called Breast-Specific Gamma Imaging (BSGI), which can detect lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal healthy cells, and generally appear as "hot spots" on the BSGI image.

Amerinet strategically partners with healthcare providers to reduce costs and improve the delivery of quality care. Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members' specific needs. To learn more, visit http://www.amerinet-gpo.com.

About Dilon Technologies

Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com.


'/>"/>
SOURCE Dilon Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dilon Technologies Announces National Agreement with MedAssets
2. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
3. Dilon Technologies Appoints New VP of Sales & Business Development
4. Dilon Technologies Explores Improvements in Molecular Breast Imaging
5. Wound Management Technologies, Inc. Announces Filing of a 510K
6. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
7. Althea Technologies Appoints E.J. Brandreth to Vice President of Quality and Regulatory
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare-Related E-Prescribing Legislation
9. VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29
10. Cadient Groups GEL Interactive Technologies Celebrates Major Milestones for Immerse Exhibit Platform: 500th Exhibit Implementation and 250,000th Healthcare Professional Registered with Immerse Exhibit Platform
11. VNUS Medical Technologies, Inc. Announces Board of Director Resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... , ... ... ... For Immediate Release                Contact: ... Shows Young Women Seek Sex and Relationship Advice from their ...
(Date:8/18/2017)... New York, NY (PRWEB) , ... August 18, ... ... the launch of this summer’s edition of “Vision & Hearing,” advocating for active, ... The campaign focuses on resources available for individuals with hearing impairments and shares ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a ... charity drive to generate community support for efforts to educate the local population on ... for all types of cancer. , Each day in America, roughly 4,600 new ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning services to communities in east Texas, is launching a regional charity effort ... , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... management and financial planning firm that serves residential and commercial clients in the ... charity drive to raise community support for the fight against cancer. , Founded ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... 2017 Insightin Health, provider of data-driven ... engagement, announced the selection of Michael Wood ... effective as of February 2017. In this role, Wood ... for our clients. Wood brings with him more ... business analytics within the healthcare industry. Wood formerly ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: